Inhibitory and excitatory alcohol-seeking cues distinct roles in behavior, neurochemistry, and mesolimbic pathway in alcohol preferring (P) rats-Reference-Cited by-同舟云学术

Inhibitory and excitatory alcohol-seeking cues distinct roles in behavior, neurochemistry, and mesolimbic pathway in alcohol preferring (P) rats

Published:2023-05 Issue: Volume:246 Page:109858
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Hauser Sheketha R.,Deehan Gerald A.,Knight Christopher P.,Waeiss Robert A.,Engleman Eric A.,Ding Zheng-Ming,Johnson Phillip L.,McBride William J.,Truitt William A.,Rodd Zachary A.

Funder

National Institutes of Health

National Institute on Alcohol Abuse and Alcoholism

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference71 articles.

1. A genetic animal model of alcoholism for screening medications to treat addiction;Bell;Int. Rev. Neurobiol.,2016

2. Dorsolateral striatum dopamine-dependent cocaine seeking is resistant to pavlovian cue extinction in male and female rats;Bender;Neuropharmacology,2021

3. Brief optogenetic inhibition of dopamine neurons mimics endogenous negative reward prediction errors;Chang;Nat. Neurosci.,2016

4. Context-induced relapse of conditioned behavioral responding to ethanol cues in rats;Chaudhri;Biol. Psychiatry,2008

5. Reinstated ethanol-seeking in rats is modulated by environmental context and requires the nucleus accumbens core;Chaudhri;Eur. J. Neurosci.,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes;European Journal of Internal Medicine;2024-09

2. A critical scientific evaluation of a purportedly negative data report – response to Seneviratne et al. 2022;Frontiers in Psychiatry;2023-10-04

3. A Phase 3 Randomized Precision Medicine Clinical Trial Using Low-Dose Ondansetron (a 5-HT3 Antagonist) to Treat Alcohol Use Disorder;2023-07-06

4. Pavlovian Spontaneous Recovery as a Measure of Alcohol-Seeking Behavior;Neuromethods;2023